Other Ingredients: Kosher gelatin (capsule), hydroxypropyl methylcellulose, cellulose and magnesium stearate.
凝胶，羟丙甲纤维素，纤维和硬脂酸镁。
ObjectiveTo compare the residue of sodium hyaluronate (SH) 1% with hydroxypropyl methylcellulose (HPMC) 2% in aqueous humor in IOL implantation.
目的比较IOL植入术中1%透明质酸钠(SH)和2%羟丙基甲基纤维素(HPMC)在房水中的残留量。
MethodsPower of cornstalk and hydroxypropyl methylcellulose (HPMC) were used as excipients to prepare camellia saponin controlled-release tablet.
方法以玉米秆粉末和羟丙甲基纤维素作为片剂辅料，制备油茶皂苷控释片。
Method: GBE sustained-release tablets were prepared by direct compression method using sodium carboxymethylcellulose CMC-Na and hydroxypropyl methylcellulose HPMC as matrix excipients.
方法：以溶胀性材料羧甲基纤维素钠和羟丙甲基纤维素为骨架材料，直接粉末压片制备银杏提取物缓释片。
Hydroxypropyl methylcellulose (HPMC) was used as the main sustained release excipient of Naoluotong sustained release Capsules, and the formula was optimized by the orthogonal experimental design.
以羟丙甲基纤维素作为主要的缓释辅料，采用正交设计方法优化处方研制成脑络康缓释胶囊。
Method Orthogonal design is used to determine the relation of the amount as well as proportion of hydroxypropyl methylcellulose and Carbopol with in vitro release and adhesive force of the tablets.
方法采用正交设计方法，确定生物粘附材料羟丙甲纤维素、卡波姆的用量及配比与制剂体外释放度及粘附力的关系。
OBJECTIVE Breviscapine sustained-release tablets(BST)were formulated with hydroxypropyl-methylcellulose as the matrix material and the release mechanism of the tablets was studied.
目的以羟丙甲基纤维素为骨架材料制得灯盏花素缓释片，并对释药机制进行探讨。
OBJECTIVE Breviscapine sustained-release tablets(BST)were formulated with hydroxypropyl-methylcellulose as the matrix material and the release mechanism of the tablets was studied.
目的以羟丙甲基纤维素为骨架材料制得灯盏花素缓释片，并对释药机制进行探讨。
应用推荐